Long-term capital infusion approvals have already been secured by Tata Sons' board, officials revealed. The conglomerate had announced plans in the final quarter of 2022 to invest $90 billion in emerging industries by 2027, including mobile components, semiconductors, electric vehicles, batteries, renewable energy, and ecommerce.